- I2 = 14.7%, heterogeneity (within design) p = 0.29, inconsistency (between designs) p = 0.33. Individual trial (comparison) rmstD are given in Table 1. As a convention, the cells contain the difference in restricted mean survival time in months (rmstD; 95% confidence interval) of the treatment with the higher number compared to the treatment with the lower number. For example, the cell that joins treatments 4 (CRT) and 5 (CRT-AC) gives the rmstD of treatment 5 vs. 4 (CRT-AC vs. CRT)
- Same direction of treatment effect but difference in significance between HR and rmstD
- Different direction of treatment effect but both HR and rmstD are not significant
- AC adjuvant chemotherapy, CRT concomitant chemoradiotherapy, HR hazard ratio, IC induction chemotherapy, rmstD restricted mean survival time difference, RT radiotherapy
- *Comparison with only one trial